News about Biotechnology

FUJIFILM Biotechnologies Enhances UK Manufacturing with Advanced Downstream Purification System

FUJIFILM Biotechnologies has announced plans to deploy its proprietary downstream purification system at its manufacturing facility in the United Kingdom, aiming to enhance production efficiency and expand biopharmaceutical processing capabilities.

Biotechnology | 09/02/2026 | By Darshana |  179

Slingshot Backs New Precision Oncology Venture from Crick Research

Slingshot Therapeutics, Syncona’s accelerator platform for advancing early-stage drug discovery programmes, has launched ALTx Therapeutics with an initial £12.55 million funding commitment from Syncona, the Francis Crick Institute, and Cancer Research Horizons.

Biotechnology | 07/02/2026 | By Darshana |  245

Japan Patent Boosts Marvel's Neurology Pipeline for MB-204

Marvel Biosciences Corporation, through its subsidiary Marvel Biotechnology Inc., has secured a key intellectual property milestone after the Japan Patent Office granted a patent covering its lead therapeutic candidate, MB-204.

Biotechnology | 05/02/2026 | By Darshana |  193

UK Industry Body Finds Sanofi in Breach Over RSV Therapy Claims Against Pfizer

A UK pharmaceutical industry watchdog has ruled that Sanofi breached the country’s code of practice by making misleading claims about its respiratory syncytial virus (RSV) therapy in comparison with a rival product from Pfizer.

Biotechnology | 04/02/2026 | By Darshana |  258

Tenacia and Golden Age Health Partner to Commercialise Ztalmy for CDKL5 Deficiency Disorder in China

Tenacia Biopharmaceuticals has granted Golden Age Health exclusive rights to commercialise Ztalmy, the first approved therapy for CDKL5 deficiency disorder, in Mainland China.

Biotechnology | 03/02/2026 | By News Bureau |  340

Piramal Pharma Solutions Commercialises Tablet-in-Capsule Technology at Indian Manufacturing Sites

Piramal Pharma Solutions has successfully developed and commercialised a tablet-in-capsule drug delivery system in India, enabling flexible dosing, dual-release profiles and improved patient-centric oral therapies.

Biotechnology | 03/02/2026 | By News Bureau |  324

USA Biomanufacturing Investment Surges Nearly 20 Percent, Report Finds

Investment in biomanufacturing across the USA has recorded a sharp rise, with pledged capital increasing by nearly 20 percent since 2024, according to a recent industry report. The surge positions biomanufacturing as one of the fastest-growing segments within the country’s advanced manufacturing landscape.
<br />

Biotechnology | 31/01/2026 | By Darshana |  269

Defence Therapeutics Advances Precision Radiopharmaceutical Development with CNL

Defence Therapeutics Inc., a publicly traded biotechnology company focused on precision intracellular drug delivery, has announced an expansion of its long-standing collaboration with Canadian Nuclear Laboratories (CNL) to accelerate the development of its radiopharmaceutical pipeline.

Biotechnology | 30/01/2026 | By Darshana |  161

Lilly Bets Big on Precision Immunology in USD 1.93 Billion Partnership

Eli Lilly and Company has entered into a strategic collaboration with biotechnology firm Repertoire Immune Medicines in a deal valued at up to USD 1.93 billion to develop novel therapies for autoimmune diseases.

Biotechnology | 30/01/2026 | By Darshana |  205

FDA Grants Breakthrough Therapy Designation to Biogen's Litifilimab for Cutaneous Lupus

Biogen’s investigational monoclonal antibody litifilimab receives FDA Breakthrough Therapy designation, marking a major step toward targeted treatment for cutaneous lupus erythematosus.

Biotechnology | 29/01/2026 | By News Bureau |  321